InvestorsHub Logo
Followers 239
Posts 12039
Boards Moderated 0
Alias Born 08/14/2003

Re: None

Monday, 03/18/2019 2:30:57 PM

Monday, March 18, 2019 2:30:57 PM

Post# of 203908
Sorry, but as I see it, the jury is still out. In this case, the jury is the people who approve patents. If the jury says patent approved, the story is dramatically improved. If the jury is hung, doing nothing, not rejecting, or approving the patents, trials that go beyond Phase 1 would be difficult or impossible to fund, as anyone could make the product if the patents aren't issued.

I don't know what may have been told the visitor to the company about where things are WRT patent approval, but clearly until they happen everything is up in the air. I believe trials to date are being run cheaply as the Israeli hospitals doing the work are willing to take some royalty income rather than being paid for their services. That's fine for Phase 1, but when you go to Phase 2 and beyond the trials should expand to multiple locations, some outside of Israel, and hopefully some sites here in the U.S. The cost is dramatically higher, and the protocol should be documented on clinical trials, or a similar database in order to attract the needed patients.

To really move on, we need the jury to come in positively for at least the drugs where Phase 2 is being planned. Without that, I believe the best we'll see is a series of delays and promises unmet.

Gary